Tightly regulated Doxycycline (Dox)-inducible lentiviral vectors for human myeloprotective gene therapy: in vitro and CD34+ - xenotransplant studies

被引：0
|
作者：
Lachmann, N. [1 ,2 ]
Hillje, R. [1 ,2 ]
Kuhn, A. [1 ,2 ]
Brennig, S. [1 ,2 ]
Dahlmann, J. [3 ]
Heinz, N. [2 ]
Gruh, I. [3 ]
Schiedlmeier, B. [2 ,3 ]
Baum, C. [2 ]
Moritz, T. [1 ,2 ]
机构：
[1] Hannover Med Sch, REBIRTH Cluster Excellence, Reprogramming & Gene Therapy Grp, Hannover, Germany
[2] Hannover Med Sch, Inst Expt Hematol, Hannover, Germany
[3] Hannover Med Sch, Leibniz Res Labs Biotechnol & Artificial Organs L, Hannover, Germany
来源：
HUMAN GENE THERAPY | 2013年 / 24卷 / 12期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：A71 / A72
页数：2
相关论文
共 50 条
  • [1] Tightly Regulated Doxycycline (Dox)-Inducible Lentiviral Vectors for Human Myeloprotective Gene Therapy: In Vitro and CD34+-Xenotransplant Studies
    Lachmann, Nico
    Hilje, Roman
    Brennig, Sebastian
    Dahlmann, Julia
    Heinz, Niels
    Gruh, Ina
    Schiedlmeier, Bernd
    Baum, Christopher
    Moritz, Thomas
    MOLECULAR THERAPY, 2013, 21 : S123 - S123
  • [2] Improved Doxycycline (Dox)-inducible lentiviral vectors in human hematopoiesis regulating Cytidine Deaminase Expression
    Lachmann, Nico
    Hillje, Roman
    Dahlmann, Julia
    Heinz, Niels
    Gruh, Ina
    Baum, Christopher
    Moritz, Thomas
    HUMAN GENE THERAPY, 2012, 23 (10) : A147 - A147
  • [3] Hybrid HIV/MSCV LTR enhances transgene expression of lentiviral vectors in human CD34+ hematopoietic cells
    Choi, JK
    Hoang, N
    Vilardi, AM
    Conrad, P
    Emerson, SG
    Gewirtz, AM
    STEM CELLS, 2001, 19 (03) : 236 - 246
  • [4] Autoregulatory lentiviral vectors allow multiple cycles of doxycycline-inducible gene expression in human hematopoietic cells in vivo
    Centlivre, M.
    Zhou, X.
    Pouw, S. M.
    Weijer, K.
    Kleibeuker, W.
    Das, A. T.
    Blom, B.
    Seppen, J.
    Berkhout, B.
    Legrand, N.
    GENE THERAPY, 2010, 17 (01) : 14 - 25
  • [5] Autoregulatory lentiviral vectors allow multiple cycles of doxycycline-inducible gene expression in human hematopoietic cells in vivo
    M Centlivre
    X Zhou
    S M Pouw
    K Weijer
    W Kleibeuker
    A T Das
    B Blom
    J Seppen
    B Berkhout
    N Legrand
    Gene Therapy, 2010, 17 : 14 - 25
  • [6] Critical factors influencing stable transduction of human CD34+ cells with HIV-1-derived lentiviral vectors
    Haas, DL
    Case, SS
    Crooks, GM
    Kohn, DB
    MOLECULAR THERAPY, 2000, 2 (01) : 71 - 80
  • [7] Genome Editing of Inducible Cell Lines for Scalable Production of Improved Lentiviral Vectors for Human Gene Therapy
    Cantore, Alessio
    Milani, Michela
    Annoni, Andrea
    Lengler, Johannes
    Bartolaccini, Sara
    Di Tomaso, Tiziano
    Holmes, Michael C.
    Scheiflinger, Friedrich
    Lombardo, Angelo
    Naldini, Luigi
    MOLECULAR THERAPY, 2016, 24 : S115 - S115
  • [8] Successful transfer of ADA gene in vitro into human peripheral blood CD34+ cells by transfecting EBV-based episomal vectors
    Satoh, E
    Hirai, H
    Inaba, T
    Shimazaki, C
    Nakagawa, M
    Imanishi, J
    Mazda, O
    FEBS LETTERS, 1998, 441 (01) : 39 - 42
  • [9] Human CD34+ hematopoietic progenitor cell-directed lentiviral-mediated gene therapy in a xenotransplantation model of lysosomal storage disease
    Hofling, AA
    Devine, S
    Vogler, C
    Sands, MS
    MOLECULAR THERAPY, 2004, 9 (06) : 856 - 865
  • [10] Optimized lentiviral transduction process for ex vivo CD34+ hematopoietic stem cell gene therapy drug product manufacture
    Masdeu, M. del Mar
    Elavazhagan, S.
    Crawford, G.
    Du, L.
    Enjalbert, F.
    Georgiou, A.
    Janakan, S.
    Pennucci, V.
    Wantuch, S.
    Whiting, C.
    Recchi, C.
    Carbonaro-Sarracino, D. A.
    Thrasher, A. J.
    Wolfe, J.
    Gaspar, H. B.
    Mavilio, F.
    Sagoo, P.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A99 - A99
12345